Prelude Capital Management, LLC Bausch Health Companies Inc. Transaction History

Prelude Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $24,522 - $33,174	-1,648 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $3,047 - $4,696	229 Added 16.14%	1,648 $30,000
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $1,129 - $2,631	-87 Reduced 5.78%	1,419 $22,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $11,730 - $19,803	-621 Reduced 29.2%	1,506 $45,000
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $44,411 - $54,578	2,127 New	2,127 $46,000
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $31,272 - $40,309	-1,524 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $25,004 - $32,494	-1,236 Reduced 44.78%	1,524 $38,000
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $18,398 - $29,537	1,043 Added 60.75%	2,760 $51,000
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $35,438 - $44,075	1,717 New	1,717 $44,000

258

255M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.33B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.